Advertisement

Topics

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 3, 2015 -- PBYI

20:00 EDT 4 Jun 2015 | Globe Newswire

NEW YORK, June 5, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Puma Biotechnology Inc. ("Puma Biotechnology") (NYSE:PBYI) between July 23, 2014 and May 13, 2015.      

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Central District of California. If you purchased or otherwise acquired Puma Biotechnology shares between July 23, 2014 and May 13, 2015, your rights may be affected by this action. To get more information go to:

HTTP://ZLK.9NL.COM/PUMABIOTECHNOLOGY   

or contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.

The complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (a) the Company's New Drug Application filing would be for a positive early stage breast cancer indication, rather than the previously announced metastatic breast cancer; (b) Puma would need to submit additional safety data from preclinical carcinogenicity studies with its NDA filing, which Puma did not have; (c) the additional studies required would push the timelines for filing the NDA; and (d) the Company overstated results from its Phase III ExteNET Trial.

If you suffered a loss in Puma Biotechnology you have until August 3, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (212) 363-7171
         www.zlk.com
NEXT ARTICLE

More From BioPortfolio on "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Puma Biotechnology, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of August 3, 2015 -- PBYI"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...